Pharmacological modulation of the PI3K/AKT/GSK3β axis: a new frontier in Alzheimer’s disease treatment
Saad Misfer Alqahtani, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Ali K. Albuhadily, Mustafa M Shokr, Αθανάσιος Αλεξίου, Marios Papadakis, Gaber El-Saber Batiha
Topics & Concepts
NeuroprotectionGSK-3Signal transductionNeuroscienceMedicineKinasePathogenesisHyperactivationInsulin receptorNeurodegenerationProtein kinase ADiseaseBioinformaticsTau proteinPharmacologyGSK3BAlzheimer's diseaseNeurologyBiologyPI3K/AKT/mTOR pathwayCognitive declineCell signalingIntracellularPhosphatidylinositolLong-term potentiationLipid signalingInsulin resistanceAlzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchPI3K/AKT/mTOR signaling in cancer